{"ticker": {"uuid": "3acf1e8a-905f-445f-8ac3-90a4d2c0b0b4", "symbol": "7148", "name": "Duopharma Biotech Berhad", "exchange": "KLS", "country": "MY", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Duopharma Biotech Berhad (KLSE:DPHARMA) is a favorite amongst institutional investors who own 72%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbkZXdmZPOEdDWjFMcDVMV2RuSm5TWXh0Vk14Q0ZOUlBVR0Vac2E4VHdMbG1nMEhwMjJFdjBFNTVscEdWWEl2NGtOTUtwdTRFMDM1TFY2djZDQ1VGVmh0QTVEQmtTQjFfa0R4Q2V2eGd4RGVPdVNsQTRwanpnczAzR0dGLUtiUnNjczZV?oc=5", "source_name": "Market source", "published_at": "2025-09-14T07:00:00+00:00", "published_display": "14 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Duopharma Sees Changes In Board Composition", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNcl80Y01lX2lHMnlKRkJLYlI1b1RXVlZRZ0h2RnBoTUJPRTY2S2ROSHgyVzVVdEs5cW9WamZCbVI2RVZSS1gyUC0xY0swRlZfbGtuQkNrTFlzYU5CZjQ1SE1IdzVxV3VxeHVGSGtwNjc2SnhKNUJDSWNTNDFsN3lGbHJodlgxZE4zWEphYUhCUVY3QQ?oc=5", "source_name": "BusinessToday Malaysia", "published_at": "2025-05-21T07:00:00+00:00", "published_display": "21 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Duopharma Biotech partners with RenalWorks to enhance dialysis services in Malaysia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE01UkwwYXNLVWtzaTNaUXpOT2M2NG5SRV9TazYtWGZ5M2xIMnkwMTZycHR6OGtjeW9IeE9YSUdnby12SmN3SDVvbWZjNHE1UGR1?oc=5", "source_name": "The Edge Malaysia", "published_at": "2023-12-01T08:00:00+00:00", "published_display": "01 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE04Qm44T1JRN3BvS1VnN1ZWaGpYQlFkYld2REI1Q3lnY1FSU2NsZ2hxclBobjFITW4zZHhCUHVFUXhmeU9Ib2NwVXFOTko0Sy04al9aY1JVTVZablFYaUZGZEJZZlFPbDI0?oc=5", "source_name": "aap.com.au", "published_at": "2023-07-25T07:00:00+00:00", "published_display": "25 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Duopharma Biotech Berhad (KLSE:DPHARMA) is a favorite amongst institutional investors who own 72%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbkZXdmZPOEdDWjFMcDVMV2RuSm5TWXh0Vk14Q0ZOUlBVR0Vac2E4VHdMbG1nMEhwMjJFdjBFNTVscEdWWEl2NGtOTUtwdTRFMDM1TFY2djZDQ1VGVmh0QTVEQmtTQjFfa0R4Q2V2eGd4RGVPdVNsQTRwanpnczAzR0dGLUtiUnNjczZV?oc=5", "source_name": "Market source", "published_at": "2025-09-14T07:00:00+00:00", "published_display": "14 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Duopharma Sees Changes In Board Composition", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNcl80Y01lX2lHMnlKRkJLYlI1b1RXVlZRZ0h2RnBoTUJPRTY2S2ROSHgyVzVVdEs5cW9WamZCbVI2RVZSS1gyUC0xY0swRlZfbGtuQkNrTFlzYU5CZjQ1SE1IdzVxV3VxeHVGSGtwNjc2SnhKNUJDSWNTNDFsN3lGbHJodlgxZE4zWEphYUhCUVY3QQ?oc=5", "source_name": "BusinessToday Malaysia", "published_at": "2025-05-21T07:00:00+00:00", "published_display": "21 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Duopharma Biotech partners with RenalWorks to enhance dialysis services in Malaysia", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE01UkwwYXNLVWtzaTNaUXpOT2M2NG5SRV9TazYtWGZ5M2xIMnkwMTZycHR6OGtjeW9IeE9YSUdnby12SmN3SDVvbWZjNHE1UGR1?oc=5", "source_name": "The Edge Malaysia", "published_at": "2023-12-01T08:00:00+00:00", "published_display": "01 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE04Qm44T1JRN3BvS1VnN1ZWaGpYQlFkYld2REI1Q3lnY1FSU2NsZ2hxclBobjFITW4zZHhCUHVFUXhmeU9Ib2NwVXFOTko0Sy04al9aY1JVTVZablFYaUZGZEJZZlFPbDI0?oc=5", "source_name": "aap.com.au", "published_at": "2023-07-25T07:00:00+00:00", "published_display": "25 Jul 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.22, "latest_week": "2026-07-17", "one_week_move": -1.6, "four_week_move": 0.0, "twelve_week_move": -5.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.096536, "market_dynamics_buy_signal": false, "relative_strength": -8.871108, "fair_value_gap": 0.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.8433, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.6% over one week, +0.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 1}, {"label": "BusinessToday Malaysia", "count": 1}, {"label": "The Edge Malaysia", "count": 1}, {"label": "aap.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.6% over one week, +0.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Duopharma Biotech Berhad (KLSE:DPHARMA) is a favorite amongst institutional investors who own 72%"}], "updated_at": "2026-07-18T18:48:37.656821+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}